Upper gastrointestinal physiology and diseases
- PMID: 25857514
- DOI: 10.3109/00365521.2015.1009157
Upper gastrointestinal physiology and diseases
Abstract
Nordic research on physiology and pathophysiology of the upper gastrointestinal tract has flourished during the last 50 years. Swedish surgeons and physiologists were in the frontline of research on the regulation of gastric acid secretion. This research finally led to the development of omeprazole, the first proton pump inhibitor. When Swedish physiologists developed methods allowing the assessment of acid secretion in isolated oxyntic glands and isolated parietal cells, the understanding of mechanisms by which gastric acid secretion is regulated took a great step forward. Similarly, in Trondheim, Norway, the acid producing isolated rat stomach model combined with a sensitive and specific method for determination of histamine made it possible to evaluate this regulation qualitatively as well as quantitatively. In Lund, Sweden, the identification of the enterochromaffin-like cell as the cell taking part in the regulation of acid secretion by producing and releasing histamine was of fundamental importance both physiologically and clinically. Jorpes and Mutt established a center at Karolinska Institutet in Stockholm for the purification of gastrointestinal hormones in the 1960s, and Danes followed up this work by excelling in the field of determination and assessment of biological role of gastrointestinal hormones. A Finnish group was for a long period in the forefront of research on gastritis, and the authors' own studies on the classification of gastric cancer and the role of gastrin in the development of gastric neoplasia are of importance. It can, accordingly, be concluded that Nordic researchers have been central in the research on area of the upper gastrointestinal physiology and diseases.
Keywords: Gastritis; Helicobacter pylori; gastroduodenal-clinical; hormones and receptors.
Similar articles
-
The physiological background behind and course of development of the first proton pump inhibitor.Scand J Gastroenterol. 2015 Jun;50(6):680-4. doi: 10.3109/00365521.2015.1013981. Epub 2015 Apr 9. Scand J Gastroenterol. 2015. PMID: 25857639 Review.
-
The regulation of gastric acid secretion - clinical perspectives.Acta Physiol (Oxf). 2014 Feb;210(2):239-56. doi: 10.1111/apha.12208. Epub 2013 Dec 27. Acta Physiol (Oxf). 2014. PMID: 24279703 Review.
-
Control of gastric acid secretion in health and disease.Gastroenterology. 2008 Jun;134(7):1842-60. doi: 10.1053/j.gastro.2008.05.021. Epub 2008 May 12. Gastroenterology. 2008. PMID: 18474247 Review.
-
Edkins and a century of acid suppression.Digestion. 2005;72(2-3):129-45. doi: 10.1159/000088368. Epub 2005 Sep 16. Digestion. 2005. PMID: 16172550
-
Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.Scand J Gastroenterol. 2010 Apr;45(4):389-94. doi: 10.3109/00365520903477348. Scand J Gastroenterol. 2010. PMID: 20001749 Review.
Cited by
-
Role of Helicobacter pylori on cancer of human adipose-derived mesenchymal stem cells and metastasis of tumor cells-an in vitro study.Tumour Biol. 2016 Mar;37(3):3371-8. doi: 10.1007/s13277-015-4137-0. Epub 2015 Oct 7. Tumour Biol. 2016. PMID: 26446460
-
The Role of Somatostatin in the Gastrointestinal Tract.Biology (Basel). 2025 May 16;14(5):558. doi: 10.3390/biology14050558. Biology (Basel). 2025. PMID: 40427747 Free PMC article. Review.
-
Addressing the Gaps in the Vitamin B12 Deficiency 2024 NICE Guidelines: Highlighting the Need for Better Recognition, Diagnosis, and Management of Pernicious Anaemia.Eur J Clin Nutr. 2025 Jul;79(7):607-610. doi: 10.1038/s41430-025-01583-4. Epub 2025 Feb 21. Eur J Clin Nutr. 2025. PMID: 39984701 Free PMC article. Review.
-
Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.FEBS Open Bio. 2018 Jan 2;8(2):279-294. doi: 10.1002/2211-5463.12365. eCollection 2018 Feb. FEBS Open Bio. 2018. PMID: 29435418 Free PMC article.
-
Predictors for the Development of Hypergastrinemia in Maintenance Treatment for Mild Gastroesophageal Reflux Disease Using a Half-dose Proton Pump Inhibitor.J Neurogastroenterol Motil. 2025 Jan 31;31(1):119-128. doi: 10.5056/jnm24128. J Neurogastroenterol Motil. 2025. PMID: 39779209 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources